Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma

被引:35
作者
Okada, T
Iizuka, N
Yamada-Okabe, H
Mori, N
Tamesa, T
Takemoto, N
Tangoku, A
Hamada, K
Nakayama, H
Miyamoto, T
Uchimura, S
Hamamoto, Y
Oka, M
机构
[1] Yamaguchi Univ, Sch Med, Dept Surg 2, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Fac Engn, Dept Comp Sci & Syst Engn, Ube, Yamaguchi 7558611, Japan
[3] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Pharmaceut Res Dept 4, Kamakura, Kanagawa 2478530, Japan
[4] Yamaguchi Univ, Sch Med, Dept Bioregulatory Funct, Ube, Yamaguchi 7558505, Japan
关键词
p53; DNA chip; gene expression; hepatocellular carcinoma; cancer;
D O I
10.1016/S0014-5793(03)01345-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To clarify the role of p53 in 22 hepatitis C virus (HCV)-infected hepatocellular carcinomas (HCCs), we compared the gene expression profiles of HCCs with wild-type p53 (wt-p53) (n = 17) and those with mutant-type p53 (mt-p53) (n=5) by oligonucleotide microarray analysis. Among 83 p53-related genes identified by a supervised learning method, 25 were underexpressed, and 58 were overexpressed in mt-p53 HCCs compared with wt-p53 HCCs. With a computer search, we identified consensus p53-binding sequences in the 3-kb region upstream of the translation initiation site in 59 of the 83 genes, suggesting that the in vivo p53-associated transcription system is very complicated. These data will provide additional insights into p53-related pathogenesis in HCV-infected HCC. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:583 / 590
页数:8
相关论文
共 27 条
  • [1] Bates S, 1996, ONCOGENE, V13, P1103
  • [2] Carreira CM, 2001, CANCER RES, V61, P8079
  • [3] DIAMOND RH, 1996, AM J PHYSIOL, V71, pG121
  • [4] Regulation of p53 downstream genes
    El-Deiry, WS
    [J]. SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) : 345 - 357
  • [5] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [6] Feitelson MA, 1997, AM J PATHOL, V150, P1141
  • [7] Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
    Harris, CC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20): : 1442 - 1455
  • [8] Hayashi H, 1995, HEPATOLOGY, V22, P1702
  • [9] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [10] p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation
    Honda, K
    Sbisà, E
    Tullo, A
    Papeo, PA
    Saccone, C
    Poole, S
    Pignatelli, M
    Mitry, RR
    Ding, S
    Isla, A
    Davies, A
    Habib, NA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (05) : 776 - 782